HIGHLIGHTS
- who: The Oncologist and collaborators from the Department of Medical Oncology, Hacettepe University Cancer Institute, Ankara, Turkey Department of Internal Medicine, Hacettepe University Faculty of Medicine, Ankara, Turkey , Bone Marrow Transplantation Unit, Hacettepe University Cancer Institute, Ankara, Turkey , Immuno-Oncology Program and , Task Force, Ares Pharmaceuticals, StPaul, MN, USA , have published the paper: Impact of Therapy in Patients with Hematologic Malignancies on Seroconversion Rates After SARS-CoV-2 Vaccination, in the Journal: (JOURNAL)
- what: The authors report a systematic literature review regarding the antibody response to SARS-CoV-2 vaccination in patients with hematologic malignancies . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.